ISRAELI BIOTECH COMPANY

Dr Reddy's pick up 6.5 per cent stake in Israeli biotech company Edity

The Hyderabad-based company informed the bourses that it has picked up 10,14,442 Preferred A-1 shares, equivalent to 6.46 per cent of Edity’s share capital on a fully diluted basis, for US$1.9715 per share, by way of conversion of SAFE (simple agreement for future equity).